Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

• Autoři: SPANJAART AM; LJUNGMAN P; DE La Camara R; TRIDELLO G; ORTIZ-MALDONADO V; URBANO-ISPIZUA A; BARBA P; KWON M; CABALLERO D; SESQUES P; BACHY E; DI Blasi R; THIEBLEMONT C; CALKOEN F; MUTSAERS P; MAERTENS J; GIANNONI L; NICHOLSON E; COLLIN M; VAZ CP; METAFUNI E; MARTINEZ-LOPEZ J; DIGNAN FL; RIBERA JM; NAGLER A; FOLBER František; SANDERSON R; BLOOR A; CICERI F; KNELANGE N; AYUK F; KROGER N; KERSTEN MJ; MIELKE S
• Rok publikování: 2021
• Druh: Článek v odborném periodiku
• Časopis / Zdroj: Leukemia
• Fakulta / Pracoviště MU: Lékařská fakulta
• Doi: http://dx.doi.org/10.1038/s41375-021-01466-0